This Continuing Education activity is supported by an educational grant from Merck, Sharp and Dohme Corp.
Last year's historic UN meeting set the stage for the fight against noncommunicable diseases. What are our next steps in stopping this slow-moving hurricane?
According to the ADA, best practice is to pack at least twice as much medications and glucose testing supplies as normally needed to minimize complications due to travel delays or lost luggage.3 Many manufacturers of insulin pumps will provide a loaner for international travel.
Our research focuses on the clinical and economic outcomes of patients receiving care from a payer-designated specialty pharmacy program compared with regular retail pharmacies.
Dispensing errors can be costly for the pharmacist as well as potentially dangerous for the patient. Pharmacists can take simple steps to help eliminate this problem.
This commentary proposes a research agenda that could inform policymaking based on a broader understanding the economic and social costs and benefits of specialty pharmaceuticals.
Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.
Medication therapy management has become an important buzzword in the world of pharmacy.
In response to the financial crisis driven by the coronavirus disease 2019 (COVID-19) pandemic, drug manufacturers are aiming to increase access to insulin products.
Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
An overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Angiotensin-II is the newest vasopressor available on the market.
Ron Lanton III, Esq, president of True North Political Solutions, LLC, discusses how recently proposed transparency legislation may affect specialty pharmacies.
The time has come to be proactive in finding a path that can benefit all potential stakeholders, rather than letting other third parties define the system in a way that negatively affects potential outcomes.
A new documentary has been released that underscores the need for accelerating alternative pathways for new discoveries that hold the promise for curing patients.
Prostate cancer prevention, irinotecan-induced diarrhea, smoking cessation, and more.
Dose consolidation and quantity limit initiatives decreased utilization and cost outcomes for select mental health drugs in a fee-for-service Medicaid environment.
Since the introduction of the new formulation of OxyContin, drug makers have sought innovative ways to curb the abuse of painkillers.
New and forthcoming oral anticoagulants, which do not require prothrombin time monitoring, will offer patients and providers additional therapeutic options.
The ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Touted by U.S. News & World Report as a top career for 2009, pharmacy offers unique opportunities for growth and professional fulfillment.